CKD Bio Corp. (KRX:063160)
23,000
+150 (0.66%)
At close: Jun 5, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Drug Substance | 133.93B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Drug Substance Growth | 7.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Probiotics | 19.06B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Probiotics Growth | -23.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Botulinum Toxin | 7.36B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Botulinum Toxin Growth | 23.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Ingredients and Health Functional Foods | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceutical Ingredients and Health Functional Foods Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Europe | 56.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | 50.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | 37.64B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | -22.58% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea | 37.18B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | -19.04% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Middle East | 12.90B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Middle East Growth | 89.94% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 16.35B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -5.71% |
Log In |
Log In |
Log In |
Log In | Upgrade
|